SUDEEPPHRM Share Price | Sudeep Pharma Ltd Stock Analysis & Recommendation

Q: Why is Sudeep Pharma Ltd falling/rising?

As of 08-Feb, Sudeep Pharma Ltd's stock price is rising, currently at 638.00, reflecting a change of 19.2 (3.1%) upward. The stock has shown strong performance over the past week, with a return of +4.91%, significantly outperforming the Sensex, which increased by only +1.59%. Over the past month, Sudeep Pharma has gained +8.03%, while the Sensex has declined by -1.74%. Year-to-date, the stock is up +5.90%, contrasting with the Sensex's drop of -1.92%.Today's trading activity indicates a positive trend, as the stock opened with a gain of 3.34% and reached an intraday high of Rs 649.15, marking a 4.9% increase. Additionally, Sudeep Pharma has been on a consecutive gain streak for the last two days, accumulating a total return of 6.67% during this period. The stock is also trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward momentum.However, it is worth noting that there has been a slight decline in investor participation, with delivery volume decreasing by -3.12% compared to the 5-day average. Despite this, the stock remains liquid enough for trading, suggesting that the overall positive performance and upward price movement are primarily driven by strong returns relative to the benchmark and consistent gains over recent days.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.23 lacs (253.58%) Volume

Shareholding (Dec 2025)

FII

1.67%

Held by 13 FIIs

DII

10.86%

Held by 11 DIIs

Promoter

76.15%

When is the next results date for Sudeep Pharma?

17-Dec-2025

The next results date for Sudeep Pharma is 19 December 2025.

View full answer

Which are the latest news on Sudeep Pharma?

08-Feb-2026

When is the next results date for Sudeep Pharma?

Why is Sudeep Pharma Ltd falling/rising?

08-Feb-2026

As of 08-Feb, Sudeep Pharma Ltd's stock price is currently at 638.00, reflecting a 3.1% increase and strong performance over the past week and month, significantly outperforming the Sensex. Despite a slight decline in investor participation, the stock shows strong upward momentum and remains liquid for trading.

View full answer

Compare Sudeep Pharma with Similar Stocks

Akums Drugs Shilpa Medicare Blue Jet Health

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 7,398 Cr (Small Cap)

P/E

52.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.10

Return on Equity

19.15%

Price to Book

9.95

Revenue and Profits:

Net Sales:

172 Cr

(Quarterly Results - Dec 2025)

Net Profit:

47 Cr

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Sudeep Pharma?

The next results date for Sudeep Pharma is scheduled for 19 December 2025....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

07-Feb-2026 | Source : BSE

Intimation for Re-schedule of Earnings Call with Analysts/Investors on 09th February 2026 at 11:00 a.m. all the investors are requested to take note of the same.

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Feb-2026 | Source : BSE

Pursuant to Regulation 30 and 47 of SEBI (LODR) please find attached newspaper publication for extract of un-audited financial results for the third quarter and nine months ended 31st December 2025.

Announcement under Regulation 30 (LODR)-Investor Presentation

07-Feb-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI (LODR) we hereby submit Investor Presentation for the unaudited financials as on third quarter and nine months ended on 31st December 2025

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

37.35

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.60

Tax Ratio

24.13%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

19.27%

ROCE (avg)

23.00%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

9.95

EV to EBIT

40.60

EV to EBITDA

38.33

EV to Capital Employed

9.11

EV to Sales

14.50

PEG Ratio

Dividend Yield

ROCE (Latest)

22.44%

ROE (Latest)

19.15%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (5.67%)

FIIs

Held by 13 FIIs (1.67%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (3.42%)

Individual Investors Holdings

3.27%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.73% vs 9.62% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -9.65% vs 18.02% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "90.28",
          "val2": "87.88",
          "chgp": "2.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.61",
          "val2": "30.87",
          "chgp": "-4.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.63",
          "val2": "2.03",
          "chgp": "-68.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "26.87",
          "val2": "29.74",
          "chgp": "-9.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.80%",
          "val2": "35.13%",
          "chgp": "-2.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.06",
          "val2": "168.40",
          "chgp": "-0.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.27",
          "val2": "60.03",
          "chgp": "2.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.47",
          "val2": "1.99",
          "chgp": "74.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "54.95",
          "val2": "41.98",
          "chgp": "30.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.46%",
          "val2": "35.65%",
          "chgp": "0.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "258.34",
          "val2": "251.88",
          "chgp": "2.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "90.88",
          "val2": "86.49",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "3.24",
          "chgp": "26.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "81.82",
          "val2": "62.61",
          "chgp": "30.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.18%",
          "val2": "34.34%",
          "chgp": "0.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "356.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.96",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "4.81",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "95.75",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.99%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

90.28

87.88

2.73%

Operating Profit (PBDIT) excl Other Income

29.61

30.87

-4.08%

Interest

0.63

2.03

-68.97%

Exceptional Items

0.00

Standalone Net Profit

26.87

29.74

-9.65%

Operating Profit Margin (Excl OI)

32.80%

35.13%

-2.33%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.73% vs 9.62% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -9.65% vs 18.02% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

168.06

168.40

-0.20%

Operating Profit (PBDIT) excl Other Income

61.27

60.03

2.07%

Interest

3.47

1.99

74.37%

Exceptional Items

0.00

Standalone Net Profit

54.95

41.98

30.90%

Operating Profit Margin (Excl OI)

36.46%

35.65%

0.81%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

258.34

251.88

2.56%

Operating Profit (PBDIT) excl Other Income

90.88

86.49

5.08%

Interest

4.10

3.24

26.54%

Exceptional Items

0.00

Standalone Net Profit

81.82

62.61

30.68%

Operating Profit Margin (Excl OI)

35.18%

34.34%

0.84%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

356.73

Operating Profit (PBDIT) excl Other Income

131.96

Interest

4.81

Exceptional Items

0.00

Standalone Net Profit

95.75

Operating Profit Margin (Excl OI)

36.99%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Sudeep Pharma Ltd

Sudeep Pharma Ltd

Small Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Sudeep Pharma

1Day

52 Week

CASH

FII

DII

Promoter

When is the next results date for Sudeep Pharma?

Watch in Real-Time

Which are the latest news on Sudeep Pharma?

Why is Sudeep Pharma Ltd falling/rising?

Compare Sudeep Pharma with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

When is the next results date for Sudeep Pharma?

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Announcement under Regulation 30 (LODR)-Newspaper Publication

Announcement under Regulation 30 (LODR)-Investor Presentation

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Half Yearly Results Snapshot (Standalone) - Sep'25

Nine Monthly Results Snapshot (Standalone) - Dec'25

Annual Results Snapshot (Standalone) - Mar'25

About Sudeep Pharma Ltd

Company Coordinates